Exercitation ullamco laboris nis aliquip sed conseqrure dolorn repreh deris ptate velit ecepteur duis.
Saptalis Pharmaceuticals, LLC is a U.S. based pharmaceutical company that specializes in the development, manufacturing, and commercialization of niche generic and innovative specialty products. The Company, founded in 2015, has developed a growing commercial product portfolio and pipeline of generic prescription and innovative pharmaceutical products utilizing ANDA and 505 (b)(2) regulatory pathways. Saptalis is strategically focused on non-sterile and sterile liquid and semi-solid dosage forms. Saptalis takes pride in its highly experienced team of scientists, state-of-the-art R&D laboratories, and the FDA inspected manufacturing facilities equipped and qualified to meet its growing commercial production needs.
Saptalis is a dynamic and growing company. We continue to invest in the future by developing complex generic and innovative products and expanding manufacturing capabilities with a focus on quality and cGMP compliance.